glp-1 obesity drug news today september 2025 New oral drugs could offer more options for weight loss GLP-1 Receptor Agonists – From

MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed

Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes

Type 2 diabetes Metformin another antidiabetes medication is considered the first line of treatment for diabetes

Victoza is specifically indicated for use in treating type 2 diabetes

76 FriasJPBastyrEJVignatiLTschpMHSchmittCOwenKet al